Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Vitamin D supplementation is unlikely to offer any health benefits

By News team

Supplementation with vitamin D does not prevent heart attack, stroke, cancer, or bone fractures and is therefore unlikely to offer any health benefits, according to a meta-analysis published in The Lancet today (24 January 2014). Furthermore, data from future trials are unlikely to change these conclusions, say the researchers.

The team, from the University of Auckland, New Zealand, performed a traditional meta-analysis followed by a trial sequential analysis of 40 existing randomised controlled trials. They found that supplementation with vitamin D or vitamin D with calcium does not reduce instances of myocardial infarction, ischaemic heart disease, stroke or cerebrovascular disease, or cancer by 15 per cent or more in participants living in the community.

Vitamin D with calcium did reduce the incidence of hip fractures in two trials involving elderly nursing home residents. In a comment accompanying the study, Karl Michaëlsson, of the Department of Surgical Sciences, Uppsala University, Sweden, attributed this to the fact that elderly nursing home residents probably have “lower serum concentrations of 25-hydroxyvitamin D [vitamin D] combined with a low calcium intake”.

However, it was uncertain whether vitamin D alone increased hip fracture incidence or had no effect. Overall, the authors concluded that vitamin D, with or without calcium, did not decrease total fracture or hip fracture by 15 per cent or more in participants living in the community.

The researchers also say that there was uncertainty as to whether vitamin D, with or without calcium, reduces the risk of death, using a risk reduction threshold of 5 per cent.

The trial sequential analysis indicated that findings from future studies with a similar design to those examined, or that differ only by dose of vitamin D, are unlikely to alter the results of the meta-analysis.

Professor Michaëlsson suggested: “Without stringent indications—ie, supplementing those without true insufficiency—there is a legitimate fear that vitamin D supplementation might actually cause net harm.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.11133309

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Hip fracture (Tallis/

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.